ABSCI CORP Earnings Per Share (Basic)
ABSCI CORP (ABSI) reported Earnings Per Share (Basic) of -$0.21 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- ABSCI CORP earnings per share, basic for the quarter ending 2026-06-30 was -$0.21.
- ABSCI CORP earnings per share, basic for the quarter ending 2026-03-31 was -$0.19.
- ABSCI CORP earnings per share, basic for the quarter ending 2025-09-30 was -$0.20.
- ABSCI CORP earnings per share, basic for the quarter ending 2025-06-30 was -$0.24.
- ABSCI CORP earnings per share, basic for fiscal 2025 was -$0.84.
- ABSCI CORP earnings per share, basic for fiscal 2024 was -$0.94.
- ABSCI CORP earnings per share, basic for fiscal 2023 was -$1.20.
- ABSCI CORP earnings per share, basic for fiscal 2022 was -$1.15.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.21 10-Q · filed 2026-08-11 | -$0.40 10-Q · filed 2026-08-11 | ||
| 2026-03-31 | -$0.19 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$0.84 10-K · filed 2026-03-24 | |||
| 2025-09-30 | -$0.20 10-Q · filed 2025-11-12 | -$0.65 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$0.24 10-Q · filed 2026-08-11 | -$0.45 10-Q · filed 2026-08-11 | ||
| 2025-03-31 | -$0.21 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$0.94 10-K · filed 2026-03-24 | |||
| 2024-09-30 | -$0.24 10-Q · filed 2025-11-12 | -$0.46 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.68 10-Q · filed 2025-11-12 | -$0.93 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.22 10-Q · filed 2025-08-12 | -$0.44 10-Q · filed 2025-08-12 | -$0.69 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$0.93 derived: net income ÷ weighted average shares · filed 2025-08-12 |
| 2024-03-31 | -$0.22 10-Q · filed 2025-05-13 | -$0.47 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$0.71 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.16 derived: net income ÷ weighted average shares · filed 2025-05-13 |
| 2023-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.95 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$1.20 10-K · filed 2025-03-18 |
| 2023-09-30 | -$0.24 10-Q · filed 2024-11-12 | -$0.69 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.95 10-Q · filed 2024-11-12 | -$1.16 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.45 10-Q · filed 2024-08-14 | -$0.71 10-Q · filed 2024-08-14 | -$0.92 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$1.22 derived: net income ÷ weighted average shares · filed 2024-08-14 |
| 2023-03-31 | -$0.26 10-Q · filed 2024-05-14 | -$0.47 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.77 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.08 derived: net income ÷ weighted average shares · filed 2024-05-14 |
| 2022-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$0.83 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$1.15 10-K · filed 2024-03-21 |
| 2022-09-30 | -$0.30 10-Q · filed 2023-11-14 | -$0.62 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.94 10-Q · filed 2023-11-14 | -$1.22 derived: net income ÷ weighted average shares · filed 2023-11-14 |
| 2022-06-30 | -$0.32 10-Q · filed 2023-08-14 | -$0.64 10-Q · filed 2023-08-14 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$1.25 derived: net income ÷ weighted average shares · filed 2023-08-14 |
| 2022-03-31 | -$0.33 10-Q · filed 2023-05-15 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$1.78 derived: net income ÷ weighted average shares · filed 2023-05-15 |
| 2021-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.60 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$1.51 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$2.08 10-K · filed 2023-03-30 |
| 2021-09-30 | -$0.33 10-Q · filed 2022-11-09 | -$1.45 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$2.16 10-Q · filed 2022-11-09 | -$2.70 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-06-30 | -$2.39 10-Q · filed 2022-08-11 | -$3.13 10-Q · filed 2022-08-11 | -$3.53 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$4.41 derived: net income ÷ weighted average shares · filed 2022-08-11 |
| 2021-03-31 | -$0.70 10-Q · filed 2022-05-11 | -$1.06 derived: net income ÷ weighted average shares · filed 2022-05-11 | -$1.89 derived: net income ÷ weighted average shares · filed 2022-05-11 | -$2.99 derived: net income ÷ weighted average shares · filed 2022-05-11 |
| 2020-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$1.18 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$2.29 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$3.19 10-K · filed 2022-03-22 |
| 2020-09-30 | -$0.85 10-Q · filed 2021-11-09 | -$1.97 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$2.88 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$1.12 10-Q · filed 2021-09-07 | -$2.02 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |